NCT02182544View on ClinicalTrials.gov

WAL801CL (Epinastine Hydrochloride) Dry Syrup in Paediatric Perennial Allergic Rhinitis

PHASE3CompletedINTERVENTIONAL
Enrollment

151

Participants

Timeline

Start Date

June 30, 2001

Primary Completion Date

December 31, 2001

Conditions
Rhinitis, Allergic, Perennial
Interventions
DRUG

WAL801CL dry syrup

DRUG

Ketotifen fumarate dry syrup

DRUG

Ketotifen fumarate dry syrup placebo

DRUG

WAL 801 CL dry syrup placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY